Controlled-release levodopa methyl ester/benserazide-loaded nanoparticles ameliorate levodopa-induced dyskinesia in rats

BACKGROUND: Levodopa remains the most effective drug in the treatment of Parkinson’s disease. However, long-term administration of levodopa induces motor complications, such as levodopa-induced dyskinesia. The mechanisms underlying levodopa-induced dyskinesia are not fully understood. METHODS: In th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xinxin, Zheng, Ruiyuan, Cai, Yunpeng, Liao, Meiling, Yuan, Weien, Liu, Zhenguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356186/
https://www.ncbi.nlm.nih.gov/pubmed/22619544
http://dx.doi.org/10.2147/IJN.S30463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356186/
https://www.ncbi.nlm.nih.gov/pubmed/22619544
http://dx.doi.org/10.2147/IJN.S30463

Ejemplares similares